191
GR 320
NFIDENTIAL
CONFIDENTIAL
FCO 20190OZ JUN 79
TO PRIORITY HONG KONG (GOVERNOR AND BCARFE);
TELEGRAM NUMBER 423 OF 20 JUNE
JEAFFERSON'S LETTER OF 23 MARCH TO MCLAREN
AIR SERVICES ON THE LONDON/HONG KONG ROUTE
HkK 184/1
HAND
No
2 5 JUN1979
PA
1825.6
38
*^.51
1. TWO UK AIRLINES, BRITISH CALEDONIAN AND LAKER HAVE NOW PUT IN
APPLICATIONS TO THE CIVIL AVIATION AUTHORITY TO OPERATE SCHEDULED
SERVICES ON THE LONDON-HONG KONG ROUTE, WE HAVE ALL ALONG REASLISED
THAT THE RECEIPT OF ANY SUCH APPLICATIONS WOULD CALL INTO QUEST-
ION THE PROPRIETY OF UK GOVERNMENT INVOLVEMENT IN A CONTINUING
STUDY, THE PURPOSE OF WHICH COULD BE SEEN AS CONFLICTING WITH THE OBLIGATIONS IMPOSED UPON THE CAA IN RELATION TO THE LICENCE APPLI-
CATIONS UNDER THE 1971 CIVIL AVIATION ACT AND ON THE DEPARTMENT
AS THE APPELLATE BODY FROM THE AUTHORITY'S DECISIONS.
2. THE SECRETARY OF STATE FOR TRADE, WHO IS THE RESPONSIBLE UK GOVERNMENT MINISTER UNDER THE ACT, HAS, AFTER CAREFULLY WEIGHING ALL THE PROS AND CONS, DECIDED THAT HE IS NOT (REPEAT NOT) TREPARED TO DIRECT THE CIVIL AVIATION AUTHORITY NOT (REPEAT NOT) TO PROCEED
WITH THE DUE PROCESSES CONSEQUENT UPON THE RECEIPT OF LICENCE
APPLICATIONS AND THEREFORE ANY FURTHER UK GOVERNMENT INVOLVEMENT
IN THE JOINT STUDY WILL HAVE FORTHWITH TO CEASE. THE DEPARTMENT OF
TRADE WILL BE WRITING TO YOU VERY SHORTLY EXPLAINING FULLY HOW HONL
KONG INTERESTS MAY BE SAFEGUARDED IN THE DUE PROCESSES WHICH MUST
NOW FOLLOW.
3. WE DO NOT THINK THE WORK WHICH HAS BEEN DONE BOTH IN THE UK AND
IN HONG KONG AND JOINTLY ON THE STUDY SO FAR WILL HAVE BEEN WASTED,
MUCH OF IT WILL BE USEFUL IN PREPARING YOUROWN EVIDENCE, SHOULD YOU CHOOSE TO GIVE IT, BEFORE THE CAA HEARING, AND IN PRESENTING YOU CASE TO THE SECRETARY OF STATE FOR TRADE ON APPEAL, SHOULD THIS ARISE. THERE ARE A NUMBER OF LIMITATIONS (EG ON THE DISCLOSURE OF
THE CONTENTS OF CMU'S) BUT THESE WILL BE COVERED IN THE LETTER
REFERRED TO IN PARA 2 ABOVE.
CARRINGTON
FILES
MAED
HKIGD
COPIES PASSED CAD/DOT]
CONFIDENTIAL
No comments yet.
Private notes are available after approval.